Eureka Therapeutics

Eureka Therapeutics

Eureka Therapeutics

Eureka Therapeutics, a clinical stage biopharmaceutical company with the goal of curing cancer by developing novel Tcell therapies that harness the evolutionary power of the immune system.
Type
B2b
Founded
2006
Follow us
Alexa global traffic share
Team Size
1–10
Employees
FinSMEs

Eureka Therapeutics Closes $45M Series E Financing

Scientific American

Retooling T Cell Therapies to Target Solid Tumors

FinSMEs

Eureka Therapeutics Closes $60M Series D Financing

Health Funding